Clinical Trials Logo

Angina, Unstable clinical trials

View clinical trials related to Angina, Unstable.

Filter by:

NCT ID: NCT01617863 Completed - Clinical trials for Myocardial Infarction

Hemodynamics During the Soccer Championship 2012

Start date: June 2012
Phase: N/A
Study type: Observational

The purpose of this study is to determine in soccer fans whether and to which extend positive or negative emotions during the European soccer Championship affects Central Hemodynamics, Arterial Stiffness, Heartrate and Endothelial Dysfunktion.

NCT ID: NCT01556126 Completed - Clinical trials for Acute Myocardial Infarction

Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population

PARTICIPATE
Start date: February 2012
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate safety and efficacy performances of CRE8 Drug Eluting Stent, in patients comparable to the everyday's clinical practice population, with a specific focus on diabetics, that will be part of a pre-specified study subgroup.

NCT ID: NCT01543373 Completed - Stable Angina Clinical Trials

Optical Coherence Tomography Comparison of Neointimal Coverage Between CRE8 DES and BMS

DEMONSTRATE
Start date: January 2012
Phase: N/A
Study type: Interventional

The purpose of the study is to demonstrate the non-inferiority of Cre8 (CID) Drug Eluting Stent, studied 3 months after implant, compared to Vision/Multilink8 Bare Metal Stent (Abbott) studied at 1 month, in terms of neointimal coverage, determined by Optical Coherence Tomography (OCT), as percentage of cross-sections with RUTTS (Ratio of Uncovered to Total Stent Struts Per Cross Section) score ≤ 0.3.

NCT ID: NCT01539603 Completed - Clinical trials for Coronary Artery Disease

Comparison of Drug Eluting Balloon and Drug Eluting Stent

DEBfirst
Start date: April 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of Drug-Eluting Balloon first and then bare metal stent compared with drug-eluting stent for treatment of de novo lesions (DEB first).

NCT ID: NCT01522417 Completed - Clinical trials for Myocardial Infarction

Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention

SAVI-PCI
Start date: April 2012
Phase: Phase 2
Study type: Interventional

The purpose this study is to assess whether a tirofiban regimen of a high-dose bolus plus a shortened infusion duration compared to label-dosing eptifibatide in patients undergoing percutaneous coronary intervention (PCI) is associated with a non-inferior composite rate of death, PCI-related myocardial infarction, urgent target vessel revascularization or in-hospital major bleeding within 48 hours following PCI or hospital discharge, whichever comes first.

NCT ID: NCT01407146 Completed - Clinical trials for Acute Coronary Syndrome

Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study

Start date: July 2011
Phase:
Study type: Observational

The primary aim of this study is to increase our understanding of care-seeking behavior surrounding heart attacks or acute coronary syndromes [ACS]. This study uses an internet based survey to ask individuals how they obtained medical care in the midst of a heart attack. At present, care-seeking delay among individuals stricken with a heart attack prevents them from obtaining the full therapeutic benefit of hospital based medical care in a timely manner to reduce the long term health consequences of a heart attack. By using a self-tailoring survey instrument the study attempts to take into consideration the complex social processes by which the individual and their family make decisions to seek medical care for symptoms of a heart attack. The study is designed to obtain a national sample of ACS care-seeking behavior in the United States.

NCT ID: NCT01377402 Completed - Clinical trials for Coronary Artery Disease

ARgentinean Risk Assessment Registry in ACS; the ARRA-RACS Study

ARRA-RACS
Start date: November 2005
Phase: N/A
Study type: Observational

The first aim of this trial is to assess the long-term prognostic value of Omega-3 index, which is a measure of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) relative to other fatty acids in the erythrocyte membrane, in an unselected, regional multicenter observational study of 982 chest pain patients admitted to the emergency unit, employing blood samples collected at admission. The second purpose of this study is to evaluate the prognostic utility of vitamin D in the same population. The third purpose of this study is to assess the incremental prognostic value of B-type natriuretic peptide (BNP) and high-sensitive C-reactive protein (hsCRP).

NCT ID: NCT01373502 Completed - Stable Angina Clinical Trials

International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions

NEXT
Start date: October 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate non-inferiority in terms of safety and efficacy of DES Limus Carbostent compared to the Taxus Liberté in treating de-novo atherosclerotic lesions in native coronary arteries.

NCT ID: NCT01370278 Completed - Clinical trials for Myocardial Infarction

Clearance Of Mucus In Stents (COMIS)

Start date: June 16, 2011
Phase: N/A
Study type: Interventional

The goal of this clinical research study is to compare the effects of sodium bicarbonate to normal saline when used for clearing mucus blockage in patients with airway stents.

NCT ID: NCT01331967 Completed - Clinical trials for Diabetic Unstable Angina

The Effect of Pioglitazone on Neointima Volume and Characteristics Observed by Optical Coherence Tomography (OCT)

Start date: February 2011
Phase: Phase 4
Study type: Interventional

Pioglitazone is used in the treatment of diabetic patients. Thiazolidinediones increase insulin sensitivity and show favorable effect on blood glucose levels and lipid profiles. The effect of pioglitazone on atherosclerotic and inflammatory markers has not been compared in prospective manner after everolimus-eluting stent implantation by OCT. The purpose of this prospective, randomized, open-label trial is to compare the effect of pioglitazone on neointima volume and atherosclerosis progression in type 2 diabetic patients by using OCT. Moreover, changes in neointima characteristics could be analyzed along with the changes in miRNA-21, -126, -143, -145. Major adverse cardiovascular events such as non-fatal MI, death, stroke, and TLR could be compared.